| Methods | Type of study: RCT (abstract) Method of treatment allocation: not described Stratification: not described Placebo: yes, saline Sample size calculation: not stated Intention‐to‐treat analyses: not stated Losses to follow‐up: not stated Funding: not stated |
|
| Participants | Location: Temple University Hospital, Philadelphia, Pennsylvania, USA Timeframe: July 1976‐July 1978 Eligibility criteria: any pregnant woman expected to deliver prior to 34 weeks' gestation between July 1976 and July 1978 at Department of Obs & Gyne at Temple University Hospital Gestational age range: prior to 34 weeks Exclusion criteria: not stated Total recruited: 45 placebo, 47 steroids | |
| Interventions | Treatment group received an IM injection of betamethasone. The control group received an IM injection of saline as placebo. | |
| Outcomes | Neonatal mortality, RDS | |
| Notes | ||
| Risk of bias | ||
| Bias | Authors' judgement | Support for judgement |
| Random sequence generation (selection bias) | Unclear risk | Not stated other than "randomized" |
| Allocation concealment (selection bias) | Unclear risk | Not stated |
| Blinding of participants and personnel (performance bias) All outcomes | Low risk | Likely that participants were blinded and possible that study personnel were blinded due to the use of placebo |
| Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Blinding of outcome assessor not stated |
| Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Not stated |
| Selective reporting (reporting bias) | High risk | RDS is the only outcome reported. |
| Other bias | Unclear risk | Only available as an abstract ‐ does not appear to have been published |